← SynDRA
GSK-LSD1
SynDRA canonical compound SYN1946047 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KDM1A |
|---|
| Mechanism of action | histone lysine demethylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- N-[(1R,2S)-2-phenylcyclopropyl]piperidin-4-amine
- N-((1R,2S)-2-phenylcyclopropyl)piperidin-4-amine
- RefChem:144534
- GSK-LSD1 Dihydrochloride
- GSK-LSD-1
- GSK-LSD1?
- GTPL8241
- orb1942512
- SCHEMBL14880683
- SCHEMBL30283576
- CHEBI:232752
- BDBM256459
- AKOS030573682
- EBC-520381
- GSK-LSD1, >=98% (HPLC)
- NCGC00356416-07
- AS-85721
- HY-100546
- CS-0019691
- T82254
- US9487512, 3
- N-[(1r,2s)-2-phenylcyclopropyl]-4-piperidinamine
- GSK-LSD1 (HYDROCHLORIDE)
- AKOS025147353
- GSK-LSD1 (DIHYDROCHLORIDE)
- GSK-LSD1 (hydrochloride)
- GSK-LSD1, >
- HY-100546A
- GSK-LSD1 (dihydrochloride)
- GSK-LSD1 2HCl
- SCHEMBL29378943
- GSK LSD1 Dihydrochloride
- CJD93395
- s7574
- AC-35986
- GSK-LSD1 2HCL
- GLXC-05267
- CS-7913
Look up GSK-LSD1 in the interactive SynDRA portal →